Necrostatin-1 mitigates renal ischemia-reperfusion injury – time dependent- via aborting the interacting protein kinase (RIPK-1)-induced inflammatory immune response.
The recently defined necroptosis process participates in the pathophysiology of several tissue injuries. Targeting the necroptosis mediator receptor-interacting protein kinase (RIPK1) by necrostatin-1 in different phases of...
Read More